Axio Biosolutions: Funding, Investors & Team (Oct 2026)
Axio is a medtech R&D and Manufacturing Company focused on Advanced Surgical and wound care. Axio has the distinction to be the first company from India to get USFDA clearance for a woundcare/hemostat product. Controlling life threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat is its flagship product developed to reduce the mortality due to traumatic bleeding. A CE approved product, Axiostat is based on a patented novel 100% chitosan platform and has variants catering to Emergency & Trauma, Military, Cardio-vascular and Dental applications.
Axio Biosolutions has raised $6.0M across 1 funding round on record, the most recent a Series B of $6.0M announced in Jul 2021.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Axio Biosolutions Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Axio Biosolutions Funding Rounds
Axio Biosolutions Founders and Leadership Team
Contact details for the Axio Biosolutions team: 1 of 1 has an email address on file.
Start 14-day free trial →Axio Biosolutions Funding Compared to Other Health Care Startups
Axio Biosolutions' latest round of $6.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Axio Biosolutions in Health Care and Bengaluru
Companies Similar to Axio Biosolutions
CureMeAbroad operates as an AI-powered medical tourism concierge, matching patients from Western markets.
betterhood is an Indian wellness brand providing products for pain relief, posture support, and active living.
InstaAstro offers individual Astrology consultations, along with Daily Activity Tracks & Content, to assist…
Lissun is a comprehensive mental health and well-being platform that aims to offer mental health remedies to…
Fibroheal Woundcare Pvt Ltd focuses on leveraging silk proteins to create biomedical applications for…
Mykare Health is constructing the largest affordable and reliable hospital network in India. So far, Mykare…
SuperLiving is a lifestyle-tech platform designed for Bharat that aims to make everyday life more attentive…
QubeHealth is a healthcare payments company. Integrating a massive ‘payments infrastructure’ in India,…
Immuneel Therapeutics is a clinical-stage biotechnology company that develops cell and gene therapies focused…
MediElaj is a digital healthcare platform designed to provide accessible medical assistance through a mobile…
SS Innovations to improve gold standard surgical procedures through the union of great skill, patient care…
Axio Biosolutions Funding FAQs
What does Axio Biosolutions do?
Axio is a medtech R&D and Manufacturing Company focused on Advanced Surgical and wound care. Axio has the distinction to be the first company from India to get USFDA clearance for a woundcare/hemostat product. Controlling life threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat is its flagship product developed to reduce the mortality due to traumatic bleeding. A CE approved product, Axiostat is based on a patented novel 100% chitosan platform and has variants catering to Emergency & Trauma, Military, Cardio-vascular and Dental applications.
How much funding has Axio Biosolutions raised?
Axio Biosolutions has raised $6.0M across 1 round on record. The most recent is a Series B of $6.0M announced in Jul 2021.
When did Axio Biosolutions last raise funding?
Axio Biosolutions' most recent funding round on record is a Series B of $6.0M, announced in Jul 2021.
Who is the CEO of Axio Biosolutions?
Leo Mavely is listed as CEO at Axio Biosolutions.
Where is Axio Biosolutions headquartered?
Axio Biosolutions is based in Bengaluru, Karnataka, India.
How many employees does Axio Biosolutions have?
Axio Biosolutions is in the 101-250 employee band.
How does Axio Biosolutions' funding compare to other Health Care startups?
Axio Biosolutions' latest round of $6.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Axio Biosolutions Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Axio Biosolutions is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.